Navigation Links
No substitute for hard work: Creatine supplementation does not improve exercise outcomes in COPD
Date:8/1/2008

Creatine, a popular nutritional supplement renowned for enhancing athletic performance and muscle strength, does not improve exercise outcomes in patients with chronic obstructive pulmonary disease (COPD), according to a new study. The randomized, placebo-controlled, double-blind study provided the most powerful evidence to date that the effect of creatine (Cr) supplementation was negligible at best among these patients.

"We have evidence to suggest Cr uptake into muscles [in COPD patients] but are unable to explain why an increase in muscle Cr did not enhance training," wrote the study's lead author, Sarah Deacon, M.D., specialist registrar at the Institute for Lung Health at Glenfield Hospital in Leicester, England.

The results were published in the first issue for August of the American Journal of Respiratory and Critical Care Medicine by the American Thoracic Society (ATS).

Cr supplementation has been shown to improve short-burst, high-intensity exercise function in athletes, as well as enhancing isometric muscle strength, lower body endurance and lean body mass in the elderly. To determine whether Cr supplementation could similarly enhance the physical condition of COPD patients, Dr. Deacon and co-researchers recruited 100 patients with COPD to either receive Cr or a placebo over the course of a seven week pulmonary rehabilitation program.

Those who were randomized to the placebo group were give lactose supplements that appeared identical to the Cr-containing supplements. Following a five-day loading period (22g/d Cr or 24 g/d lactose) each subject followed maintenance dosing of 3.76 or 4 g of Cr or lactose respectively.

Of the original 100 subjects, 80 successfully completed the study. In both control and Cr groups, there were statistically significant improvements in functional and muscular performance during the loading phase, but no differences were seen between the groups. The Cr group also showed a greater, but non-significant percentage of improvement in the incremental shuttle walking test with loading and after pulmonary rehabilitation, but additional analysis still showed no overall effect between it and the placebo group.

"The most likely explanation is that any benefits of creatine have been submerged by the large training effect of physical training alone," wrote Dr. Deacon.

This study, therefore, further validates that there is no substitute for the old-fashioned hard work that is an essential element of pulmonary rehabilitation. "Those of us interested in pulmonary rehabilitation are happy to see confirmation of the beneficial effects of exercise training. This information indicates that creatine supplementation not be viewed as a good substitute for exercise traininggood news for adepts of pulmonary rehabilitation," wrote Francoise Maltais, M.D., Didier Saey, Ph.D., and Richard Debigare, Ph.D., all of the Centre de Recherche de l'Hospital Laval Quebec in Canada.

"Without minimizing the importance of the quest to optimize the results of pulmonary rehabilitation, we had to appreciate that only a small portion of patients with COPD actually engage in pulmonary rehabilitation.so improved [access] is important for PR to achieve its full potential from a public health perspective."

Dr. John Heffner, past president of the ATS, commented that "these and other studies are finally gaining recognition that pulmonary rehabilitation is an essential element of comprehensive care for patients with COPD. The weight of the evidence has succeeded in gaining Medicare payment for rehabilitation services, which has been one of our major hurdles to access."


'/>"/>

Contact: Keely Savoie
ksavoie@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

Related medicine news :

1. Blood Substitute Found Safe in Large Phase III Trial
2. Smokeless Tobacco: Not a Harmless Substitute
3. NuVasive Acquires First Stem Cell Bone Graft Substitute
4. Northfield Laboratories Inc. Comments on Article and Editorial on Hemoglobin-Based Blood Substitutes to be Published in May 21 JAMA
5. Experimental Blood Substitutes Unsafe, Study Finds
6. Sugar Substitutes May Contribute to Weight Gain
7. Transcutaneous cervical esophageal ultrasound can not substitute for 24-h pH monitoring or manometry
8. Compromise SCHIP Deal Substitutes Ideology for Common Sense
9. ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
10. New Drug No Substitute for Standard Blood-Clot Therapy
11. Statement From Mens Health Network: U.S. Presidential Candidates Overlook Real Problem in U.K. & U.S. Health Policies Towards Men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... In 2009, Carol Bryan ... resulted in severe facial disfiguration. After four frightening years of isolation and emotional ... Medical Center, who removed the substances in a partial facial transplant through eight ...
(Date:1/19/2017)... ... January 19, 2017 , ... Workrite Ergonomics announced this ... The Tranquility privacy panel system was designed to deliver the ideal blend of ... noise and provide the visual privacy required to maintain concentration levels and increase ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... Sam ... planning assistance to commercial and residential clients in the California Bay Area, is launching ... heart health in the region. , Heart disease is the primary killer of adult ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... which serves Lawrenceville, New Jersey and the surrounding area, is inaugurating a ... sclerosis (ALS), more commonly known as Lou Gehrig's disease or motor neurone disease, ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Spring Create Real Impact contest from Impact Teen Drivers and California Casualty. Entries ... . , Educational grants totaling $15,000 will be awarded for the best ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... , January 19, 2017 According to a ... cryotherapy is set to witness a CAGR of 6.5% during the ... will continue to be the leading market for cryotherapy ... ... are emphasizing on ensuring affordable and adequate supply of gas in ...
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... blood analysis instruments and consumables for the medical and ... discuss its financial results for the third quarter fiscal ... be at 4:15 p.m. ET on Thursday, January 26, ... third quarter fiscal year 2017 after the market closes ...
Breaking Medicine Technology: